Focus on these 4 pharma stocks: Sun Pharma, Zydus, Alembi, Rubicon on Monday
Explore key updates on Sun Pharma's major acquisition, Zydus' malaria trials, Alembic's FDA approval, and Rubicon's inspection
Explore key updates on Sun Pharma's major acquisition, Zydus' malaria trials, Alembic's FDA approval, and Rubicon's inspection
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
